Earnings History Data for Immunome, Inc. (IMNM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Immunome, Inc.
Immunome, Inc. is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome, Inc. is based in Exton, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | IMNM | Immunome | 796.00 | -0.78 | -0.60 | 0.00 | Immunome, Inc GAAP EPS of -$0.78 misses by $0.21 [11/13/2024 6:06 PM] |
11.12 | -0.47 (-4.06%) |
11.84 | 0.25 (2.16%) |
6.93 - 30.96 | 1,100,190 | 550,000 | 1,941 | ||
| 12-08-2024 | PM | IMNM | Immunome | 776.00 | -0.49 | -0.38 | 0.00 | Immunome GAAP EPS of -$0.60 misses by $0.17, revenue of $2.37M beats by $0.5M [8/13/2024 2:07 AM] |
13.49 | 0.85 (6.76%) |
12.64 | 0.0 (0.00%) |
6.13 - 30.96 | 725,944 | 670,000 | 35,470 | ||
| 14-05-2024 | PM | IMNM | Immunome | 929.00 | -0.34 | -0.80 | 0.00 | Immunome GAAP EPS of -$2.51, revenue of $1.03M [5/14/2024 10:48 AM] |
14.71 | -0.89 (-5.73%) |
15.00 | -0.61 (-3.91%) |
4.50 - 30.96 | 1,005,145 | 750,000 | 8,495 | ||
| 12-05-2022 | PM | IMNM | Immunome, Inc. | 32.87 | -0.96 | 0.00 | -0.37 | Immunome GAAP EPS of -$0.96 misses by $0.27 [5/12/2022 8:23 AM] |
2.50 | 0.20 (8.70%) |
0.0 | 0.0 (0.00%) |
2.09 - 27.80 | 49,719 | 50,000 | 0 | ||
| 15-11-2021 | AH | IMNM | Immunome, Inc. | 219.25 | -0.65 | 0.00 | -2.54 | Immunome EPS misses by $0.14 [11/15/2021 5:19 PM] |
17.96 | 0.18 (1.01%) |
17.35 | -0.43 (-2.42%) |
9.28 - 63.78 | 177,035 | 80,000 | 130 | ||
| 16-08-2021 | AH | IMNM | Immunome, Inc. | 166.84 | -0.46 | 0.00 | 0.00 | Immunome EPS misses by $0.04 [8/19/2021 4:17 PM] |
12.50 | -0.67 (-5.09%) |
13.75 | 0.58 (4.40%) |
9.28 - 63.78 | 156,402 | 110,000 | 490 | ||